众生药业股价跌5.11%，泰信基金旗下1只基金重仓，持有1.5万股浮亏损失1.83万元

Group 1 - The core point of the news is that Zhongsheng Pharmaceutical's stock has declined by 5.11%, with a current price of 22.65 CNY per share and a total market capitalization of 19.251 billion CNY [1] - Zhongsheng Pharmaceutical, established on December 31, 2001, and listed on December 11, 2009, is primarily engaged in the research, production, and sales of pharmaceuticals [1] - The company's main business revenue composition includes: Traditional Chinese Medicine sales at 53.03%, chemical drug sales at 38.12%, Chinese medicinal materials and decoction pieces sales at 6.13%, raw materials and intermediates sales at 2.14%, and other sales at 0.58% [1] Group 2 - From the perspective of fund holdings, one fund under Taixin Fund has a significant position in Zhongsheng Pharmaceutical, with Taixin Smart Quantitative Stock Mixed Fund A (013033) holding 15,000 shares, accounting for 1.94% of the fund's net value [2] - The estimated floating loss for the fund today is approximately 18,300 CNY [2] - Taixin Smart Quantitative Stock Mixed Fund A (013033) was established on May 22, 2025, with a latest scale of 12.5156 million CNY and a cumulative return of 18.58% since inception [2]